UniSa - IRIS Institutional Research Information System

SELLERI, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.533
EU - Europa 3.497
AS - Asia 1.777
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 11
SA - Sud America 6
AF - Africa 5
Totale 21.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.503
UA - Ucraina 1.180
CN - Cina 1.011
IT - Italia 905
DE - Germania 456
IE - Irlanda 427
VN - Vietnam 422
TR - Turchia 245
FI - Finlandia 242
SE - Svezia 162
IN - India 42
GB - Regno Unito 38
EU - Europa 28
CA - Canada 27
JP - Giappone 16
RU - Federazione Russa 16
FR - Francia 10
ES - Italia 8
HK - Hong Kong 8
NL - Olanda 8
AU - Australia 7
ID - Indonesia 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
KR - Corea 6
SG - Singapore 6
PS - Palestinian Territory 5
AT - Austria 4
HU - Ungheria 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
BE - Belgio 3
CL - Cile 3
ET - Etiopia 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
MX - Messico 3
PL - Polonia 3
BG - Bulgaria 2
BR - Brasile 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
DZ - Algeria 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
MA - Marocco 1
MY - Malesia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 21.857
Salva come PNG Salva come JPEG
Città #
Ann Arbor 4.703
Woodbridge 2.446
Jacksonville 1.457
Chandler 1.347
Princeton 1.164
Houston 1.161
Wilmington 1.110
Dong Ket 422
Ashburn 420
Dublin 405
Andover 283
Nanjing 255
Izmir 245
Boardman 239
Salerno 205
Beijing 194
Pellezzano 171
Düsseldorf 145
Naples 125
Fairfield 100
Shenyang 90
Nanchang 86
Changsha 81
Hebei 77
Jiaxing 77
Redwood City 55
Washington 54
Norwalk 48
Tianjin 44
Los Angeles 42
Dearborn 37
Pune 37
Napoli 36
Cambridge 34
Seattle 29
San Diego 27
Mestre 20
Jinan 19
Falls Church 18
Grevenbroich 17
Ottawa 14
Lappeenranta 12
Munich 11
Rome 11
Tappahannock 11
Caserta 10
New York 10
Guangzhou 9
Indiana 8
Manchester 8
Milan 8
Haikou 7
Hefei 7
London 7
Palermo 7
Phoenix 7
Richmond 7
Teano 7
Zhengzhou 7
Baltimore 6
Edinburgh 6
Fisciano 6
Madrid 6
Amsterdam 5
Cava De' Tirreni 5
Costa Mesa 5
Oliveto Citra 5
Piacenza 5
Rochester 5
San Francisco 5
Tokyo 5
Toronto 5
Bellinzona 4
Catania 4
Cava de' Tirreni 4
Gunzenhausen 4
Lentini 4
Marano Di Napoli 4
Ningbo 4
Nürnberg 4
Pescara 4
Shanghai 4
Taiyuan 4
Trieste 4
Tulkarm 4
Vienna 4
Addis Ababa 3
Arienzo 3
Auckland 3
Aversa 3
Bishkek 3
Brno 3
Budapest 3
Buffalo 3
Caposele 3
Cesano 3
Chicago 3
Easton 3
Ferrara 3
Fremont 3
Totale 17.860
Salva come PNG Salva come JPEG
Nome #
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 126
Bendamustine in combination with rituximab as first line therapy for patients with chronic lymphocytic leukemia (cll): a retrospective real practice italian multicentre study. 125
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 125
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 118
High dose rHuEPO may induce complete remission in AML-M6 116
Continuous alternate-day low dose lenalidomide in combination with low dose prednisone as frontline treatment for octogenarian newly diagnosed multiple myeloma patients 113
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 113
Soluble forms of UPAR regulate adhesion, proliferation and survival of KG1 leukemic cells 111
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 110
Impact of cytokine gene polymorphisms in myelodysplastic syndromes (MDS) 109
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 109
The cleaved form of soluble urokinase-receptor stimulates migration and mobilization of mouse CD34(+) cells in vitro and in vivo 108
Higher expression of Fas receptor on CD34+ cells of chronic myelogenous leukemia correlates with hematological response to IFN-alfa. 106
Allogeneic transplantation for multiple myeloma 106
Subcutaneous low-dose IL-2 for remission maintenance in elderly acute myeloid leukemia patients. 105
High frequency of extramedullary relapse in patients transplanted for acute myeloid leukemia. 105
Fluorescent in situ hybridization with a Y probe in the follow up of sex-mismatch transplanted patients 104
Two year follow-up of cyclosporin-A in hypoplastic myelodysplastic leukemia. 104
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 102
Bendamustine in Combination with Rituximab for Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients: An Italian Retrospective Multicentre Study 102
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 101
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 101
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 100
Long-term follow-up of a pilot study with alemtuzumab and low-dose cyclosporine a for aplastic anaemia and single-lineage marrow failures. 100
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 100
Increased expression of the signaling lymphocyte-activation molecule (mSLAM) in patients with paroxysmal nocturnal hemoglobinuria (PNH). 100
Effects of leptin and IGF-1 on bone mineral density in long-term survivors after allogeneic stem cell transplantation for hematological malignancies 99
Impact of cytokine gene polymorphism in aplastic anemia (AA) 99
Ultrasound image of pleural granulocytic sarcoma. 98
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 98
Fas-mediated downmodulation of p210 BCR/ABL results in apoptosis of CD34+ cells of chronic myelogenous leukemia. 98
Imatinib as salvage therapy for patients with refractory cGVHD 98
The urokinase-receptor in infectious diseases. 98
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 98
IgH assessment of non-Hodgkin lymphoma cells on FTA cards. 98
Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome. 97
Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond. 97
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 95
Blockade of intravascular hemolysis in PNH with the terminal complement inhibitor eculizumab unmasks low-level hemolysis potentially occurring through C3 opsonization 95
Adjuvant treatment of diabetic foot 95
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 95
Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: in vitro and in vivo studies. 94
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 94
Fas-Ligand expressed on acute leukemia cells may kill Fas positive Jurkat cells. 94
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 94
Nitric oxide and cell survival: megakaryocytes say "NO". 93
The pathophysiology of aquired aplastic anemia. 93
Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia. 92
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 92
Previous occurrence of life-threatening abdominal infection is not a contraindication to marrow transplant. 92
A backwards evolution in a case of myeloproliferative disease 92
Imatinib in 34 patients with steroid-refractory chronic graft-versus-host-disease: final evaluation of the second prospective trial, according to the NIH Consensus criteria for cGvHD 92
67 kDa laminin receptor: structure, function and role in cancer and infection. 92
FAS antigen expression on normal and aplastic CD34+ cells. 92
Bone marrow long-term initiating cells are decreased after allogeneic bone marrow transplantation. 92
Cyclosporin-A may improve in vitro circulating hematopoietic progenitors growth and affects CD4 cells expressing interferon-gamma of hypoplastic myelodysplastic patients. 92
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey 92
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment 92
Farnesyltransferase inhibition may revert in vitro Fas-mediated apoptosis of clonogenic chronic myeloid leukemia cells. 91
Bendamustine in combination with rituximab for elderly patients with aggressive B non hodgkin lymphoma not eligible for anthracycline-based therapy 91
Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GvHD. 90
Subcutaneous alemtuzumab is safe and effective for treatment of global or single-lineage immune-mediated marrow failure: a pilot study from the working party aplastic anaemia (WPSAA) 90
Avascular necrosis after allogeneic hematopoietic stem cell transplantation: An observational study on the effects of zoledronic acid 90
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 90
Expression of the 67 kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation 89
Sustained long-term hematologic recovery despite a marked quantitative defect in the stem cell compartment of patients with aplastic anemia after immunosuppressive therapy. 89
Subcutaneous Alemtuzumab Is a safe and effective treatment for global or single lineage immune-mediated marrow failures: a survey from the EBMT-WPSAA. 89
Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion 89
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 89
Circulating T regulatory cells (TREG) are decreased in patients with aplastic anemia (AA). 88
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. 87
Interferon-alpha may modulate the balance between FAS-receptor and FAS-ligand expression on bone marrow chronic myeloid leukemia cells. 87
Estrogen-progestin-replacement therapy in women after stem cell transplant 87
Determination of LTC-IC numbers in patients with myelodysplastic syndromes 87
Interferon regulatory factor-1 partially mediates interferon-gamma hematopoietic inhibition. 87
Imbalance of the osteprotegerin/RANKL system in bone marrow microenvironment after allogeneic transplant of hemopoietic stem cell 86
Inhibition of interferon regulatory factor-1 expression induces interferon-gamma to stimulate CD34+ cells. 86
Endocrine disorders after autologous and allogeneic stem cell transplantation 86
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 86
Cryptozoospermia with normal testicular function after allogeneic stem cell transplantation: a case report. 85
Management of paroxysmal nocturnal haemoglobinuria in the eculizumab era: the bedside and beyond 85
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 85
Hematopoietic inhibition by interferon-gamma is partially mediated through interferon regulatory factor-1. 84
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA. 84
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 84
Role of the urokinase receptor in hematopoietic stem cell transplantation 84
Increased expression of Fas-ligand on bone marrow progenitor cells of patients with chronic myeloid leukemia. 84
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 83
All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri. 83
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 83
Immunologic reconstitution after autologous transplant with bone marrow or peripheral blood stem cells 83
Constitutive expression of interferon-gamma in stromal human marrow culures mediates hematopoietic suppression and apoptosis of CD34+ cells. 83
Expression and function of the 67kDa laminin receptor in normal and acute leukemia cells 83
The metastasis-associated 67kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. 83
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 83
EFFICACY OF ALEMTUZUMAB PLUS EXTRACORPOREAL PHOTOPHERESIS IN ADVANCED STAGE SEZARY SYNDROME: A CASE REPORT 83
Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity 83
Fine-needle cytology in the follow-up of breast carcinoma 83
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 83
Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-gamma due to phosphorylation of Stat1 and Stat3. 82
Totale 9.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.325
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019332 0 0 0 0 0 0 0 0 0 0 314 18
2019/20202.290 659 10 266 25 239 51 254 15 243 142 353 33
2020/20212.335 28 242 248 11 328 74 266 25 247 36 357 473
2021/20222.072 21 9 15 65 58 61 21 74 309 273 267 899
2022/20233.454 333 179 103 358 477 728 52 354 560 22 176 112
2023/20241.326 182 250 131 101 144 264 75 93 16 68 2 0
Totale 22.493